{"name":"Henogen","slug":"henogen","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":7,"colorKey":"immunology","drugs":[{"name":"HB-AS02V vaccine","genericName":"HB-AS02V vaccine","slug":"hb-as02v-vaccine","indication":"Chronic hepatitis B infection","status":"phase_3"},{"name":"Adjuvanted Hep B vaccine Lot 3","genericName":"Adjuvanted Hep B vaccine Lot 3","slug":"adjuvanted-hep-b-vaccine-lot-3","indication":"Prevention of hepatitis B infection","status":"phase_3"},{"name":"Adjuvanted Hepatitis B vaccine Lot 1","genericName":"Adjuvanted Hepatitis B vaccine Lot 1","slug":"adjuvanted-hepatitis-b-vaccine-lot-1","indication":"Prevention of hepatitis B infection","status":"phase_3"},{"name":"HB-AS02V","genericName":"HB-AS02V","slug":"hb-as02v","indication":"Chronic hepatitis B infection","status":"phase_3"},{"name":"HBVAXPRO vaccine","genericName":"HBVAXPRO vaccine","slug":"hbvaxpro-vaccine","indication":"Prevention of hepatitis B infection in adults and children","status":"phase_3"},{"name":"Henogen HB vaccine","genericName":"Henogen HB vaccine","slug":"henogen-hb-vaccine","indication":"Prevention of hepatitis B infection in unvaccinated or non-responsive populations","status":"phase_3"},{"name":"Henogen HBV vaccine","genericName":"Henogen HBV vaccine","slug":"henogen-hbv-vaccine","indication":"Prevention of hepatitis B virus infection","status":"phase_3"}]},{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Fendrix vaccine","genericName":"Fendrix vaccine","slug":"fendrix-vaccine","indication":"Prevention of hepatitis B infection in adults with renal insufficiency, including pre-dialysis and dialysis patients","status":"phase_3"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"Adjuvanted Hepatitis B vaccine Lot 2","genericName":"Adjuvanted Hepatitis B vaccine Lot 2","slug":"adjuvanted-hepatitis-b-vaccine-lot-2","indication":"Other","status":"phase_3"}]}],"pipeline":[{"name":"Fendrix vaccine","genericName":"Fendrix vaccine","slug":"fendrix-vaccine","phase":"phase_3","mechanism":"Fendrix is a recombinant hepatitis B vaccine that stimulates immune response against hepatitis B surface antigen using an AS04 adjuvant system to enhance immunogenicity.","indications":["Prevention of hepatitis B infection in adults with renal insufficiency, including pre-dialysis and dialysis patients","Prevention of hepatitis B in other immunocompromised populations"],"catalyst":""},{"name":"HB-AS02V vaccine","genericName":"HB-AS02V vaccine","slug":"hb-as02v-vaccine","phase":"phase_3","mechanism":"HB-AS02V is a therapeutic vaccine designed to stimulate immune responses against hepatitis B surface antigen to treat chronic hepatitis B infection.","indications":["Chronic hepatitis B infection"],"catalyst":""},{"name":"Adjuvanted Hep B vaccine Lot 3","genericName":"Adjuvanted Hep B vaccine Lot 3","slug":"adjuvanted-hep-b-vaccine-lot-3","phase":"phase_3","mechanism":"This adjuvanted hepatitis B vaccine stimulates the immune system to produce antibodies and cellular immunity against hepatitis B virus surface antigen.","indications":["Prevention of hepatitis B infection"],"catalyst":""},{"name":"Adjuvanted Hepatitis B vaccine Lot 1","genericName":"Adjuvanted Hepatitis B vaccine Lot 1","slug":"adjuvanted-hepatitis-b-vaccine-lot-1","phase":"phase_3","mechanism":"This adjuvanted hepatitis B vaccine stimulates the immune system to produce antibodies and cellular immunity against hepatitis B virus surface antigen.","indications":["Prevention of hepatitis B infection"],"catalyst":""},{"name":"Adjuvanted Hepatitis B vaccine Lot 2","genericName":"Adjuvanted Hepatitis B vaccine Lot 2","slug":"adjuvanted-hepatitis-b-vaccine-lot-2","phase":"phase_3","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"HB-AS02V","genericName":"HB-AS02V","slug":"hb-as02v","phase":"phase_3","mechanism":"HB-AS02V is a therapeutic vaccine designed to stimulate immune responses against hepatitis B surface antigen.","indications":["Chronic hepatitis B infection","Hepatitis B prevention"],"catalyst":""},{"name":"HBVAXPRO vaccine","genericName":"HBVAXPRO vaccine","slug":"hbvaxpro-vaccine","phase":"phase_3","mechanism":"HBVAXPRO is a recombinant hepatitis B surface antigen (HBsAg) vaccine that stimulates the immune system to produce antibodies against hepatitis B virus.","indications":["Prevention of hepatitis B infection in adults and children"],"catalyst":""},{"name":"Henogen HB vaccine","genericName":"Henogen HB vaccine","slug":"henogen-hb-vaccine","phase":"phase_3","mechanism":"Henogen HB vaccine stimulates the immune system to produce antibodies and cellular immunity against hepatitis B virus surface antigen.","indications":["Prevention of hepatitis B infection in unvaccinated or non-responsive populations"],"catalyst":""},{"name":"Henogen HBV vaccine","genericName":"Henogen HBV vaccine","slug":"henogen-hbv-vaccine","phase":"phase_3","mechanism":"Henogen HBV vaccine stimulates the immune system to produce antibodies and cellular immunity against hepatitis B virus antigens.","indications":["Prevention of hepatitis B virus infection"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxOc1MxdEtUQWZQOXFCdjFGQlo4RWo0UjFnaDBRN2FVWmdWQUVoZEh5UFZUWVA1OWlSbE9vcU9ZeGk2QlRCa294VWJyQ2hDQ1I4a0l0aEVwWndRNmRKeGhydjFHYkpkQ3pkZV80QV9Rd2l3VEFPVFJ1LVdxRmVkYzg0TjlKSTB0NElkclJlSGlCQQ?oc=5","date":"2026-01-15","type":"pipeline","source":"geneonline.com","summary":"Thermo Fischer Snags Novasep’s Low-Cost CMO for $879 Million - geneonline.com","headline":"Thermo Fischer Snags Novasep’s Low-Cost CMO for $879 Million","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxPRm1BNkZ2czF3cGI5R19jeFRwSW9TMWJsYVJKU2ZPQUt5MFVNRV9oU2FObnBJZ1B6ekZRdmo2dW9WbHVZQV9qVmtZUjJvTVJjYzV5UW5rWmdUZ2ZNeWNQb3d3Z1ZHTG4xdlFrNUZSQVB1UjF5VEd5bm81Qm1GN0w2RGJnNjczSDNyOEthTnl4cHhZWkh4bmU3LTBua9IBogFBVV95cUxObWRGeVZtMFIwZURTMXNCZkpUM01QdHJhV2N1amdKWjVyMUxUMVVRMk5vWm9YUnNTeVpSOU10Zl8zQmdoX3ZYRU1uMzVhWlV3SWo1MkpFXzZZWnM2MmVsYzBvcXI4UXpqZEhZRDhHTEdMNHladEZQZDR3REVfSXFlNHplRTdkVXA2SFdiZHkzbHRKOF81OFpCNExGd0VFcEtmaGc?oc=5","date":"2022-06-07","type":"pipeline","source":"Indian Chemical News","summary":"Thermo Fisher completes acquisition of Henogen - Indian Chemical News","headline":"Thermo Fisher completes acquisition of Henogen","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxPZkQ5d29PbEF1MWc4NlVwWUwyeFQtcl9UbmxRZzVZYWlqZjR4UHpiaWpwNGNLam12d3BOVFY5ajFjQjQ3dWJEbmFKRUtpSHhuMWx5RzNjZmZlcEdwcXEtbVcydnhLN3dSMjRNc1RGYWx2U0pQNG9NRWNqTmxKc1hFM0RZSjc?oc=5","date":"2021-01-18","type":"deal","source":"Pharmaceutical Technology","summary":"Thermo Fisher Scientific acquires Novasep’s Henogen for $874.5m - Pharmaceutical Technology","headline":"Thermo Fisher Scientific acquires Novasep’s Henogen for $874.5m","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigJBVV95cUxPMUtiWmMtRWFOQU92RkhIUVE4UEJCdldvaGdJNElpLXNWNXg5TnRlZU5vQTJnNVl1b0RNazl2aS1Pbko4SWxuYURYRlQ3SWpJTHMxTGpNT0oxMmtFTEZkd21KWnNjY21ZZEl3VlVWajZMYTQ4dFRvT3JyUkJ1cjlVbHJZTzNBMm1LOFNtNnd0REdlZFJxOXN1b2hpbjBPaDlPc2ZlUDJ3c0xrTHdXd3NFdjVocE9VQ0FDWnkwamdiVDFHYTU2dExGN2JvMDdJVDhrNlh0NWZ0WFN4OVhDdzhxdEVkVm1BSEYtVVJXWHItUkoyV2V3OG15UFVzTTBoTkxodkxxQ1NBUEFTUQ?oc=5","date":"2021-01-15","type":"deal","source":"Thermo Fisher Scientific","summary":"Thermo Fisher Scientific Acquires Viral Vector Manufacturing Business from Novasep - Thermo Fisher Scientific","headline":"Thermo Fisher Scientific Acquires Viral Vector Manufacturing Business from Novasep","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxQbC1NdlEwenNUUWE5UmFnTjJuR19DaTR4cm03ZUgwX2NqbTdSWjFYdGFLSWx5ajlxdDloaGVUS0RsSkl1dFVzRGN5NWRRRlg1dnJMc2ROUjkxemZ0Wk9INk5UUHhzNDc3TkppS0RsMG51ejlSNmdFb1c0SzZ4czk0cU90Z3RueDlxTGRYcmJYbFU5THFB?oc=5","date":"2021-01-15","type":"deal","source":"Drug Discovery News","summary":"Thermo Fisher Scientific buys Henogen from Novasep - Drug Discovery News","headline":"Thermo Fisher Scientific buys Henogen from Novasep","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxNbk5OWnZOSEZSLXNaeWhaUUlScjF4ampZRVI3UVVZcEcxbUpBMUhUZTFtVmVvVm5IQWMtQTVuTEJyT2ZZek9iUk1tOHFwVUxHaGpCbVJ4emFydmJ2T1lobDlVRzNzckFUVlFaTzNIaFpDRTJWQ2IwMTYxeDlHYTBGOUpzMWUxTHJ6MC0tdnFBV1p1MW5maHNoTHdrSm5ndk5tNTZSTWxWbjV3eF9XMzJvMTBmc3A?oc=5","date":"2021-01-15","type":"pipeline","source":"Fierce Biotech","summary":"JPM: Thermo Fisher picks up Novasep's viral vector business for $878M outright - Fierce Biotech","headline":"JPM: Thermo Fisher picks up Novasep's viral vector business for $878M outright","sentiment":"neutral"}],"patents":[],"drugCount":9,"phaseCounts":{"phase_3":9},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}